180 related articles for article (PubMed ID: 31009206)
1. Structural and Functional Studies of the Membrane-Binding Domain of NADPH-Cytochrome P450 Oxidoreductase.
Xia C; Shen AL; Duangkaew P; Kotewong R; Rongnoparut P; Feix J; Kim JP
Biochemistry; 2019 May; 58(19):2408-2418. PubMed ID: 31009206
[TBL] [Abstract][Full Text] [Related]
2. Structural and Kinetic Studies of Asp632 Mutants and Fully Reduced NADPH-Cytochrome P450 Oxidoreductase Define the Role of Asp632 Loop Dynamics in the Control of NADPH Binding and Hydride Transfer.
Xia C; Rwere F; Im S; Shen AL; Waskell L; Kim JP
Biochemistry; 2018 Feb; 57(6):945-962. PubMed ID: 29308883
[TBL] [Abstract][Full Text] [Related]
3. Conformational changes of NADPH-cytochrome P450 oxidoreductase are essential for catalysis and cofactor binding.
Xia C; Hamdane D; Shen AL; Choi V; Kasper CB; Pearl NM; Zhang H; Im SC; Waskell L; Kim JJ
J Biol Chem; 2011 May; 286(18):16246-60. PubMed ID: 21345800
[TBL] [Abstract][Full Text] [Related]
4. Crystal structure of a NADPH-cytochrome P450 oxidoreductase (CYPOR) and heme oxygenase 1 fusion protein implies a conformational change in CYPOR upon NADPH/NADP
Sugishima M; Sato H; Wada K; Yamamoto K
FEBS Lett; 2019 Apr; 593(8):868-875. PubMed ID: 30883732
[TBL] [Abstract][Full Text] [Related]
5. Probing the transmembrane structure and dynamics of microsomal NADPH-cytochrome P450 oxidoreductase by solid-state NMR.
Huang R; Yamamoto K; Zhang M; Popovych N; Hung I; Im SC; Gan Z; Waskell L; Ramamoorthy A
Biophys J; 2014 May; 106(10):2126-33. PubMed ID: 24853741
[TBL] [Abstract][Full Text] [Related]
6. Crystal structure of the FAD/NADPH-binding domain of rat neuronal nitric-oxide synthase. Comparisons with NADPH-cytochrome P450 oxidoreductase.
Zhang J; Martàsek P; Paschke R; Shea T; Siler Masters BS; Kim JJ
J Biol Chem; 2001 Oct; 276(40):37506-13. PubMed ID: 11473123
[TBL] [Abstract][Full Text] [Related]
7. Electron transfer in flavocytochrome P450 BM3: kinetics of flavin reduction and oxidation, the role of cysteine 999, and relationships with mammalian cytochrome P450 reductase.
Roitel O; Scrutton NS; Munro AW
Biochemistry; 2003 Sep; 42(36):10809-21. PubMed ID: 12962506
[TBL] [Abstract][Full Text] [Related]
8. Chimeric enzymes of cytochrome P450 oxidoreductase and neuronal nitric-oxide synthase reductase domain reveal structural and functional differences.
Roman LJ; McLain J; Masters BS
J Biol Chem; 2003 Jul; 278(28):25700-7. PubMed ID: 12730215
[TBL] [Abstract][Full Text] [Related]
9. Association of multiple developmental defects and embryonic lethality with loss of microsomal NADPH-cytochrome P450 oxidoreductase.
Shen AL; O'Leary KA; Kasper CB
J Biol Chem; 2002 Feb; 277(8):6536-41. PubMed ID: 11742006
[TBL] [Abstract][Full Text] [Related]
10. Engineering of proteolytically stable NADPH-cytochrome P450 reductase.
Bonina TA; Gilep AA; Estabrook RW; Usanov SA
Biochemistry (Mosc); 2005 Mar; 70(3):357-65. PubMed ID: 15823091
[TBL] [Abstract][Full Text] [Related]
11. Structural and kinetic investigations of the carboxy terminus of NADPH-cytochrome P450 oxidoreductase.
Hubbard PA; Xia C; Shen AL; Kim JP
Arch Biochem Biophys; 2021 Apr; 701():108792. PubMed ID: 33556357
[TBL] [Abstract][Full Text] [Related]
12. Structure and function of an NADPH-cytochrome P450 oxidoreductase in an open conformation capable of reducing cytochrome P450.
Hamdane D; Xia C; Im SC; Zhang H; Kim JJ; Waskell L
J Biol Chem; 2009 Apr; 284(17):11374-84. PubMed ID: 19171935
[TBL] [Abstract][Full Text] [Related]
13. Mutants of Cytochrome P450 Reductase Lacking Either Gly-141 or Gly-143 Destabilize Its FMN Semiquinone.
Rwere F; Xia C; Im S; Haque MM; Stuehr DJ; Waskell L; Kim JJ
J Biol Chem; 2016 Jul; 291(28):14639-61. PubMed ID: 27189945
[TBL] [Abstract][Full Text] [Related]
14. Recruitment of governing elements for electron transfer in the nitric oxide synthase family.
Jáchymová M; Martásek P; Panda S; Roman LJ; Panda M; Shea TM; Ishimura Y; Kim JJ; Masters BS
Proc Natl Acad Sci U S A; 2005 Nov; 102(44):15833-8. PubMed ID: 16249336
[TBL] [Abstract][Full Text] [Related]
15. Recombinant human cytochrome P450 1A2 and an N-terminal-truncated form: construction, purification, aggregation properties, and interactions with flavodoxin, ferredoxin, and NADPH-cytochrome P450 reductase.
Dong MS; Yamazaki H; Guo Z; Guengerich FP
Arch Biochem Biophys; 1996 Mar; 327(1):11-9. PubMed ID: 8615680
[TBL] [Abstract][Full Text] [Related]
16. Altered human CYP3A4 activity caused by Antley-Bixler syndrome-related variants of NADPH-cytochrome P450 oxidoreductase measured in a robust in vitro system.
Moutinho D; Marohnic CC; Panda SP; Rueff J; Masters BS; Kranendonk M
Drug Metab Dispos; 2012 Apr; 40(4):754-60. PubMed ID: 22252407
[TBL] [Abstract][Full Text] [Related]
17. An enzymatically active chimeric protein containing the hydrophilic form of NADPH-cytochrome P450 reductase fused to the membrane-binding domain of cytochrome b5.
Gilep AA; Guryev OL; Usanov SA; Estabrook RW
Biochem Biophys Res Commun; 2001 Jun; 284(4):937-41. PubMed ID: 11409883
[TBL] [Abstract][Full Text] [Related]
18. Mosquito NADPH-cytochrome P450 oxidoreductase: kinetics and role of phenylalanine amino acid substitutions at leu86 and leu219 in CYP6AA3-mediated deltamethrin metabolism.
Sarapusit S; Pethuan S; Rongnoparut P
Arch Insect Biochem Physiol; 2010 Apr; 73(4):232-44. PubMed ID: 20235118
[TBL] [Abstract][Full Text] [Related]
19. NADPH-cytochrome P450 oxidoreductase: prototypic member of the diflavin reductase family.
Iyanagi T; Xia C; Kim JJ
Arch Biochem Biophys; 2012 Dec; 528(1):72-89. PubMed ID: 22982532
[TBL] [Abstract][Full Text] [Related]
20. Expression, purification, and physical properties of recombinant flavocytochrome fusion proteins containing rat cytochrome b(5) linked to NADPH-cytochrome P450 reductase by different membrane-binding segments.
Gilep AA; Guryev OL; Usanov SA; Estabrook RW
Arch Biochem Biophys; 2001 Jun; 390(2):222-34. PubMed ID: 11396925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
